Search

everythinglearnresearchcommunity

for

Search:↓

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Docetaxel is effective against various cancers but mainly causes neutropenia.

The new nanoparticles could improve melanoma treatment by working better than current options.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Most patients experienced significant but reversible hair loss during treatment.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

More research is needed to understand chemotherapy-induced hair loss and its phases.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

The treatment is safe and effective for elderly patients with advanced non-small-cell lung cancer.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Nab-paclitaxel chemotherapy can rarely cause lupus-like skin issues.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Eliminating senescent cells can prevent and reverse chemotherapy-induced peripheral neuropathy.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Chemotherapy provides symptom relief and extends life in 30-50% of gynecological cancer cases, but has only cured choriocarcinoma.

Nab-paclitaxel is as effective as cisplatin but safer for early-stage cervical cancer treatment.

Some chemotherapy can cause permanent hair loss.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.